Of all patients with histologic-confirmed node-positive HNSCC of the oropharynx, larynx, hypopharynx or unknown primary (n = 908) who were consecutively treated by (chemo)radiation in our institute between 2008 and 2022, 130 patients received salvage ND (14%). These patients form the cohort for the current analysis. Patients with local RD and those received planned ND or ND in the context of late RF were not included in the current analysis.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Zeno A.
Contact Zeno A., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack